The company, Marion Biotech, bought the ingredient - propylene glycol (PG) - from trader Maya Chemtech India, as reported by Reuters. But Maya did not have a licence to sell pharmaceutical-grade materials and "dealt in industrial-grade only," according to a source at the firm with knowledge of the Marion investigation.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/dIJFZO9
via IFTTT
0 comments:
Post a Comment